CoChat

Ultra-High Mass Resolution MALDI Imaging Mass Spectrometry of Proteins and Metabolites in a Mouse Model of Glioblastoma

Open access
Dilillo, M., Ait-Belkacem, R., Esteve, C., Pellegrini, D., Nicolardi, S., Costa, M., Vannini, E., Graaf, E. L. de, Caleo, M., McDonnell, L. A. · 2017 · Scientific Reports
Cited by 172

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

MALDI mass spectrometry imaging is able to simultaneously determine the spatial distribution of hundreds of molecules directly from tissue sections, without labeling and without prior knowledge. Ultra-high mass resolution measurements based on Fourier-transform mass spectrometry have been utilized to resolve isobaric lipids, metabolites and tryptic peptides. Here we demonstrate the potential of 15T MALDI-FTICR MSI for molecular pathology in a mouse model of high-grade glioma. The high mass accuracy and resolving power of high field FTICR MSI enabled tumor specific proteoforms, and tumor-specific proteins with overlapping and isobaric isotopic distributions to be clearly resolved. The protein ions detected by MALDI MSI were assigned to proteins identified by region-specific microproteomics (0.8 mm 2 regions isolated using laser capture microdissection) on the basis of exact mass and isotopic distribution. These label free quantitative experiments also confirmed the protein expression changes observed by MALDI MSI and revealed changes in key metabolic proteins, which were supported by in-situ metabolite MALDI MSI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-00703-w

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 45

  1. McDonnell, L. A. & Heeren, R. M. A. Imaging mass spectrometry. Mass Spectrom. Rev. 26, 606–643, doi:10.1002/mas.20124 (2007). · DOI · Paper page
  2. Maier, S. K. et al. Comprehensive identification of proteins from MALDI imaging. Mol. Cell. Proteomics 12, 2901–10, doi:10.1074/mcp.M113.027599 (2013). · DOI
  3. Nicolardi, S., Van Der Burgt, Y. E. M., Dragan, I., Hensbergen, P. J. & Deelder, A. M. Identification of new apolipoprotein-CIII glycoforms with ultrahigh resolution MALDI-FTICR mass spectrometry of human sera. J. Proteome Res. 12, 2260–2268, doi:10.1021/pr400136p (2013). · DOI · Paper page
  4. Heijs, B. et al. Comprehensive analysis of the mouse brain proteome sampled in mass spectrometry imaging. Anal. Chem. 87, 1867–1875, doi:10.1021/ac503952q (2015). · DOI
  5. Jones, E. E. et al. On-tissue localization of ceramides and other sphingolipids by MALDI mass spectrometry imaging. Anal. Chem. 86, 8303–8311, doi:10.1021/ac501937d (2014). · DOI
  6. Esteve, C., Tolner, E. a., Shyti, R., van den Maagdenberg, A. M. J. M. & McDonnell, L. a. Mass spectrometry imaging of amino neurotransmitters: a comparison of derivatization methods and application in mouse brain tissue. Metabolomics 12, 30, doi:10.1007/s11306-015-0926-0 (2016). · DOI
  7. Mulder, I. A. et al. Funnel-freezing versus heat-stabilisation for the visualization of metabolites by mass spectrometry imaging in a mouse stroke model. Proteomics 16, 1652–1659, doi:10.1002/pmic.v16.11-12 (2016). · DOI
  8. McDonnell, L. a. et al. Peptide and protein imaging mass spectrometry in cancer research. J. Proteomics 73, 1921–1944, doi:10.1016/j.jprot.2010.05.007 (2010). · DOI · Paper page
  9. Poté, N. et al. Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas. Hepatology. Hepatology (Baltimore, Md.) 58, 983–994, doi:10.1002/hep.26433 (2013). · DOI
  10. Spraggins, J. M. et al. MALDI FTICR IMS of intact proteins: Using mass accuracy to link protein images with proteomics data. J. Am. Soc. Mass Spectrom 26, 947–985, doi:10.1007/s13361-015-1147-5 (2015). · DOI · Paper page
  11. Spraggins, J. M. et al. Next-generation technologies for spatial proteomics: Integrating ultra-high speed MALDI-TOF and high mass resolution MALDI FTICR imaging mass spectrometry for protein analysis. Proteomics 16, 1678–1689, doi:10.1002/pmic.v16.11-12 (2016). · DOI · Paper page
  12. Rauniyar, N. & Yates, J. R. Isobaric Labeling-Based Relative Quanti fi cation in Shotgun Proteomics. J. Proteome Res. 13, 5293–5309, doi:10.1021/pr500880b (2014). · DOI · Paper page
  13. Louie, K. B. et al. Mass spectrometry imaging for in situ kinetic histochemistry. Sci. Rep. 3, 1656, doi:10.1038/srep01656 (2013). · doi:10.1038/srep01656
  14. Marie, S. K. N. & Shinjo, S. M. O. Metabolism and brain cancer. Clinics 66, 33–43, doi:10.1590/S1807-59322011001300005 (2011). · DOI
  15. Vannini, E. et al. The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model. BMC Cancer 14, 449–458, doi:10.1186/1471-2407-14-449 (2014). · DOI
  16. Norris, J. L. et al. Processing MALDI mass spectra to improve mass spectral direct tissue analysis. Int. J. Mass Spectrom. 260, 212–221, doi:10.1016/j.ijms.2006.10.005 (2007). · DOI · Paper page
  17. McDonnell, L. A., van Remoortere, A., de Velde, N., van Zeijl, R. J. M. & Deelder, A. M. Imaging mass spectrometry data reduction: Automated feature identification and extraction. J. Am. Soc. Mass Spectrom. 21, 1969–1978, doi:10.1016/j.jasms.2010.08.008 (2010). · doi:10.1016/j.jasms.2010.08.008
  18. Mack, S. C., Hubert, C. G., Miller, T. E., Taylor, M. D. & Rich, J. N. An epigenetic gateway to brain tumor cell identity. Nat. Neurosci. 19, 10–19, doi:10.1038/nn.4190 (2015). · DOI
  19. Meier, J. L. Metabolic mechanisms of epigenetic regulation. ACS Chem. Biol. 8, 2607–2621, doi:10.1021/cb400689r (2013). · DOI · Paper page
  20. Melorose, J. et al. Metabolic regulation of histone post-translational modifications. ACS Chem. Biol. 8, 2607–2621 (2015).
  21. Shechter, D., Dormann, H. L., Allis, C. D. & Hake, S. B. Extraction, purification and analysis of histones. Nat. Protoc. 2, 1445–1457, doi:10.1038/nprot.2007.202 (2007). · DOI · Paper page
  22. Maleszewska, M. & Kaminska, B. Is glioblastoma an epigenetic malignancy? Cancers (Basel). 5, 1120–1139 (2013). · DOI · Paper page
  23. Arnaudo, A. M. & Garcia, B. a. Proteomic characterization of novel histone post-translational modifications. Epigenetics Chromatin 6, 24, doi:10.1186/1756-8935-6-24 (2013). · DOI · Paper page
  24. Lahiri, S. et al. In situ detection of histone variants and modifications in mouse brain using imaging mass spectrometry. Proteomics 16, 437–447, doi:10.1002/pmic.v16.3 (2016). · DOI
  25. Hardesty, W. M., Kelley, M. C., Mi, D., Low, R. M. & Caprioli, R. M. Protein signatures for survival and recurrence in metastatic melanoma. J. Proteomics 74, 1002–1014, doi:10.1016/j.jprot.2011.04.013 (2011). · DOI
  26. Wirsching, H. G. et al. Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma. Brain 137, 433–448, doi:10.1093/brain/awt333 (2014). · DOI
  27. Huret, J. L. et al. Atlas of genetics and cytogenetics in oncology and haematology in 2013. Nucleic Acids Res. 41, 920–924, doi:10.1093/nar/gks1082 (2013). · DOI · Paper page
  28. Nipp, M. et al. S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI Imaging. J. Mol. Med. 90, 163–174, doi:10.1007/s00109-011-0815-6 (2012). · DOI
  29. McNamara, M., Sahebjam, S. & Mason, W. Emerging Biomarkers in Glioblastoma. Cancers (Basel). 5, 1103–1119 (2013). · DOI
  30. Barnard, G. F. et al. Ubiquitin fusion proteins are overexpressed in colon cancer but not in gastric cancer. BBA - Mol. Basis Dis. 1272, 147–153, doi:10.1016/0925-4439(95)00079-8 (1995). · doi:10.1016/0925-4439(95)00079-8
  31. Lai, M. D. & Xu, J. Ribosomal proteins and colorectal cancer. Curr Genomics 8, 43–49, doi:10.2174/138920207780076938 (2007). · DOI
  32. Mi, H., Muruganujan, A., Casagrande, J. T. & Thomas, P. D. Large-scale gene function analysis with the PANTHER classification system. Nat. Protoc. 8, 1551–1566, doi:10.1038/nprot.2013.092 (2013). · DOI · Paper page
  33. Hanahan, D. & Weinberg, R. a. Hallmarks of cancer: The next generation. Cell 144, 646–674, doi:10.1016/j.cell.2011.02.013 (2011). · DOI · Paper page
  34. Wolf, A., Agnihotri, S. & Guha, A. Targeting metabolic remodeling in glioblastoma multiforme. Oncotarget 1, 552–562, doi:10.18632/oncotarget.101014 (2010). · DOI · Paper page
  35. Seyfried, T. N., Flores, R. E., Poff, A. M. & D’Agostino, D. P. Cancer as a metabolic disease: Implications for novel therapeutics. Carcinogenesis 35, 515–527, doi:10.1093/carcin/bgt480 (2014). · DOI · Paper page
  36. Kucharzewska, P., Christianson, H. C. & Belting, M. Global profiling of metabolic adaptation to hypoxic stress in human glioblastoma cells. PLoS One 10, e0116740, doi:10.1371/journal.pone.0116740 (2015). · DOI · Paper page
  37. Wishart, D. S. Applications of metabolomics in drug discovery and development. Drugs R D 9, 307–322, doi:10.2165/00126839-200809050-00002 (2008). · DOI · Paper page
  38. Chinnaiyan, P. et al. The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism. Cancer Res. 72, 5878–5888, doi:10.1158/0008-5472.CAN-12-1572-T (2012). · DOI · Paper page
  39. Hattori, K. et al. Paradoxical ATP elevation in ischemic penumbra revealed by quantitative imaging mass spectrometry. Antioxid. Redox Signal. 13, 1157–1167, doi:10.1089/ars.2010.3290 (2010). · DOI
  40. Kang, S. et al. Molecular proteomics imaging of tumor interfaces by mass spectrometry. J. Proteome Res. 9, 1157–1164, doi:10.1021/pr900666q (2010). · DOI
  41. Vannini, E. et al. Electrophysiology of glioma: a Rho GTPase-activating protein reduces tumor growth and spares neuron structure and function. Neuro. Oncol. 18, 1634–1643, doi:10.1093/neuonc/now114 (2016). · DOI
  42. Sugiura, Y., Honda, K., Kajimura, M. & Suematsu, M. Visualization and quantification of cerebral metabolic fluxes of glucose in awake mice. Proteomics 14, 829–838, doi:10.1002/pmic.v14.7-8 (2014). · DOI
  43. Enthaler, B. et al. Influence of various on-tissue washing procedures on the entire protein quantity and the quality of matrix-assisted laser desorption/ionization spectra. Rapid Commun. Mass Spectrom. 27, 878–884, doi:10.1002/rcm.6513 (2013). · doi:10.1002/rcm.6513
  44. de Graaf, E. L., Pellegrini, D. & McDonnell, L. A. A set of novel automated quantitative microproteomics protocols for small sample amounts and its application to kidney tissue substructures. J. Proteome Res 15, 4722–4730, doi:10.1021/acs.jproteome.6b00889 (2016). · DOI · Paper page
  45. McDonnell, La, Walch, A., Stoeckli, M. & Corthals, G. L. MSiMass list: A public database of identifications for protein MALDI MS imaging. J. Proteome Res. 13, 1138–1142, doi:10.1021/pr400620y (2014). · DOI

Cited by

See all 172

Metadata

Authors
Dilillo, M., Ait-Belkacem, R., Esteve, C., Pellegrini, D., Nicolardi, S., Costa, M., Vannini, E., Graaf, E. L. D., Caleo, M., & McDonnell, L. A.
Venue
Scientific Reports
Published
2017-04-04
Volume
7
Issue
1
Pages
603-603
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2598316694
Cited by
172
References
2
FWCI
10.75
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ultra-High Mass Resolution MALDI Imaging Mass Spectrometry of Proteins and Metabolites in a Mouse Model of Glioblastoma. https://app.cochat.ai/papers/10.1038/s41598-017-00703-w
The paper
Dilillo, M., Ait-Belkacem, R., Esteve, C., Pellegrini, D., Nicolardi, S., Costa, M., Vannini, E., Graaf, E. L. D., Caleo, M., & McDonnell, L. A. (2017). Ultra-High Mass Resolution MALDI Imaging Mass Spectrometry of Proteins and Metabolites in a Mouse Model of Glioblastoma. Scientific Reports. https://doi.org/10.1038/s41598-017-00703-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.